Access to vaccines and immunoglobulins Global Rabies Elimination – The Time is Now 12 December 2015 Dr Bernadette ABELA-RIDDER Team Leader, Neglected Zoonotic Diseases & WHO Rabies FP Department of the Control of Neglected Tropical Diseases World Health Organization
Improving Countries procurement systems for International organizations human and dog vaccines and rabies immunoglobulins Manufacturers Civil society and other
Exploring options to increase equity and access
Appropriate use
Intradermal administration G. Sampath
What next? • Improved procurement mechanism is needed • Forecast to ensure more stable and consistent availability at optimal price • Manufacturing capacity is driven by demand and Data • Use a revolving fund as an appropriate mechanism to support countries • Stimulus via vaccine should include support beyond the cost of the vaccines (e.g. for delivery, training, logistics). • Stockpile small amounts of RIGs Dr Bernadette ABELA-RIDDER abelab@who.int
Recommend
More recommend
